BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11711527)

  • 21. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.
    Plaksej R; Kosmala W; Frantz S; Herrmann S; Niemann M; Störk S; Wachter R; Angermann CE; Ertl G; Bijnens B; Weidemann F
    J Hypertens; 2009 Dec; 27(12):2483-91. PubMed ID: 19887955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring tissue repair and fibrosis from a distance.
    Weber KT
    Circulation; 1997 Oct; 96(8):2488-92. PubMed ID: 9355880
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation.
    Meel R; Nethononda R; Libhaber E; Dix-Peek T; Peters F; Essop M
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):150-154. PubMed ID: 29443354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure.
    Zannad F; Radauceanu A
    Heart Fail Rev; 2005 Jan; 10(1):71-8. PubMed ID: 15947894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with chronic endomyocardial fibrosis.
    Bolarin DM; Andy JJ
    Ann Clin Res; 1983 Jun; 15(3):123-7. PubMed ID: 6314867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relation between serum level of amioterminal propeptide of type I procollagen and diastolic dysfunction in hypertensive patients without diabetes mellitus: A pilot study.
    Lin YH; Chiu YW; Shiau YC; Yen RF; Tsai IJ; Ho YL; Huang PJ
    J Hum Hypertens; 2006 Dec; 20(12):964-7. PubMed ID: 17024136
    [No Abstract]   [Full Text] [Related]  

  • 27. Natriuretic peptides and collagen biomarkers in patients with medical treatment for hypertension.
    Uusimaa P; Peuhkurinen S; Ylitalo A; Vuolteenaho O; Risteli J; Peuhkurinen K;
    Acta Cardiol; 2011 Feb; 66(1):21-7. PubMed ID: 21446378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of cardiac fibrosis in hypertension.
    Díez J
    J Clin Hypertens (Greenwich); 2007 Jul; 9(7):546-50. PubMed ID: 17617765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of serum collagen types I and III metabolism products after reperfused acute myocardial infarction in patients with and without systemic hypertension.
    Cerisano G; Parodi G; Dovellini EV; Migliorini A; Tommasi M; Raspanti S; Buonamici P; Taddeucci E; Valenti R; Antoniucci D
    J Hum Hypertens; 2009 Jan; 23(1):40-7. PubMed ID: 18701924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z; Jin X; Bian P; Li X; Chen J
    Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.
    Martos R; Baugh J; Ledwidge M; O'Loughlin C; Conlon C; Patle A; Donnelly SC; McDonald K
    Circulation; 2007 Feb; 115(7):888-95. PubMed ID: 17283265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic fibrosis in rats produced by carbon tetrachloride and dimethylnitrosamine: observations suggesting immunoassays of serum for the 7S fragment of type IV collagen are a more sensitive index of liver damage than immunoassays for the NH2-terminal propeptide of type III procollagen.
    Ala-Kokko L; Günzler V; Hoek JB; Rubin E; Prockop DJ
    Hepatology; 1992 Jul; 16(1):167-72. PubMed ID: 1618469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients.
    Lin YH; Shiau YC; Yen RF; Lin LC; Wu CC; Ho YL; Huang PJ
    Ultrasound Med Biol; 2004 Jul; 30(7):885-91. PubMed ID: 15313321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan.
    Bentsen KD; Horn T; Risteli J; Risteli L; Engström-Laurent A; Hørslev-Petersen K; Lorenzen I
    Liver; 1987 Dec; 7(6):339-46. PubMed ID: 3437796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.
    van der Sluis IM; Hop WC; van Leeuwen JP; Pols HA; de Muinck Keizer-Schrama SM
    Horm Res; 2002; 57(5-6):170-9. PubMed ID: 12053089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
    TORAFIC Investigators Group
    Clin Ther; 2011 Sep; 33(9):1204-1213.e3. PubMed ID: 21906812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
    Weber KT; Brilla CG; Campbell SE; Zhou G; Matsubara L; Guarda E
    Blood Press; 1992 Aug; 1(2):75-85. PubMed ID: 1366263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects.
    McNulty M; Mahmud A; Spiers P; Feely J
    J Hum Hypertens; 2006 Nov; 20(11):867-73. PubMed ID: 16598292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
    Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.